Prime Medicine Inc (PRME) Stock Price, Quote & News

Company Profile

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate is PM359 for Chronic Granulomatous Disease, which is in Phase 1/2 clinical trial; PM577 for Wilson Disease, that is in preclinical studies; and PM647 to treat genetic disorder caused by mutations in the SERPINA1 gene, resulting in production of misfolded Z-AAT protein that accum...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 465 0013

Website: primemedicine.com

Address:

60 First Street, Cambridge, United States

PorkchopSquats May. 13 at 12:06 PM

$PRME Daily candles.

0 · Reply

JFDI May. 12 at 6:28 PM

i dont ever want to look at your guys $PRME again. ever

1 · Reply

ATTAB0Y May. 12 at 5:19 PM

$PRME CDG back on the menu with a side of AI. https://www.benchling.com/blog/prime-medicine-used-benchlings-ai-scientist

2 · Reply

ATTAB0Y May. 12 at 4:09 PM

$PRME ASGCT ANNUAL MEETING

1 · Reply

arg195 May. 12 at 1:29 PM

$PRME his absolute fewness... How does he do it???

0 · Reply

PorkchopSquats May. 12 at 9:49 AM

$PRME Presentation today at 11:30am. May be a nothingburger, but notable since their imminent IND is for their Wilson’s treatment. We shall see.

0 · Reply

NewEarth May. 11 at 10:21 PM

$NTLA $PRME $BEAM $JNJ $REGN

0 · Reply

Sambiase May. 11 at 10:10 PM

$PRME The exact largest short sellers in PRME are not publicly disclosed in real time because U.S. short positions are mostly anonymous. However, based on the latest available SEC filings and institutional disclosures, the most commonly identified firms with meaningful short exposure or trading activity in PRME include: Ikarian Capital LLC Boothbay Fund Management LLC Jane Street Group LLC Group One Trading LLC Simplex Trading LLC

1 · Reply